Publications by authors named "Christina Westermann"

Bifidobacteria are common inhabitants of the human gastrointestinal tract that, despite a long history of research, have not shown any pathogenic potential whatsoever. By contrast, some bifidobacteria are associated with a number of health-related benefits for the host. The reported beneficial effects of bifidobacteria include competitive exclusion of pathogens, alleviation of symptoms of irritable bowel syndrome and inflammatory bowel disease, and modulation of intestinal and systemic immune responses.

View Article and Find Full Text PDF

Health-promoting effects have been attributed to a number of Bifidobacterium sp. strains. These effects as well as the ability to colonise the host depend on secreted proteins.

View Article and Find Full Text PDF

The DNA sequence upstream of the glyceraldehyde 3-phosphate dehydrogenase gene (gap) of various strains of bifidobacteria is used in a number of vector systems for homologous and heterologous expression in this group of bacteria. To date none of the bifidobacterial gap promoters (Pgap) have been verified experimentally. Here, we probe a range of putative bifidobacterial promoters hypothesized to show high constitutive transcriptional activity using a β-glucuronidase reporter system.

View Article and Find Full Text PDF

Bifidobacteria are one of the predominant bacterial groups of the human intestinal microbiota and have important functional properties making them interesting for the food and dairy industries. Numerous in vitro and preclinical studies have shown beneficial effects of particular bifidobacterial strains or strain combinations on various health parameters of their hosts. This indicates the potential of bifidobacteria in alternative or supplementary therapeutic approaches in a number of diseased states.

View Article and Find Full Text PDF

Bifidobacteria are important gastrointestinal commensals of a number of animals, including humans, and various beneficial effects on host health have been attributed to them. Here, we announce the noncontiguous finished genome sequence of Bifidobacterium longum E18, isolated from a healthy adult, which reveals traits involved in its interaction with the host.

View Article and Find Full Text PDF

Here, we report on the first completely annotated genome sequence of a Bifidobacterium bifidum strain. B. bifidum S17, isolated from feces of a breast-fed infant, was shown to strongly adhere to intestinal epithelial cells and has potent anti-inflammatory activity in vitro and in vivo.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Christina Westermann"

  • - Christina Westermann's research primarily focuses on the beneficial effects and interactions of bifidobacteria with the host, particularly their roles in gut health and potential therapeutic applications.
  • - Her studies include evaluating bifidobacterial adhesion to host tissues, characterizing genetic elements like promoters, and exploring health-promoting traits attributed to various Bifidobacterium strains.
  • - Findings indicate that bifidobacteria not only show no pathogenic potential but also possess capabilities such as competing with harmful pathogens and contributing to immune modulation, highlighting their relevance in food and therapeutic contexts.